United States

SGX Pharmaceuticals Inc (SGXP)

Track

Ticker: SGXP
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Reich Siegfried VP, Drug Discovery Officer
Transaction date
Planned sale
Price
227.39
Quantity 33,496 -3.5%
Value US$821,312
Myers W Todd CFO Officer
Transaction date
Planned sale
Price
435.09
Quantity 95,647 -27.8%
Value US$2,087,386
Reich Siegfried VP, Drug Discovery Officer
Transaction date
Planned sale
Price
53.21
Quantity 91,324 +14.9%
Value US$51,004
Reich Siegfried VP, Drug Discovery Officer
Transaction date
Planned sale
Price
3.05
Quantity 681 -2.8%
Value US$2,077
BVF PARTNERS L P/IL Indirect Beneficial Owner Large shareholder
Transaction date
Purchase
Price
3.07
Quantity 7,000 +0.1%
Value US$21,489
BVF PARTNERS L P/IL Indirect Beneficial Owner Large shareholder
Transaction date
Purchase
Price
3.07
Quantity 2,000 +0.0%
Value US$6,140
BVF PARTNERS L P/IL Indirect Beneficial Owner Large shareholder
Transaction date
Purchase
Price
3.07
Quantity 3,500 +0.1%
Value US$10,744
BVF PARTNERS L P/IL Indirect Beneficial Owner Large shareholder
Transaction date
Purchase
Price
3.03
Quantity 236,000 +4.5%
Value US$715,033
BVF PARTNERS L P/IL Indirect Beneficial Owner Large shareholder
Transaction date
Purchase
Price
3.03
Quantity 68,000 +1.3%
Value US$206,026
BVF PARTNERS L P/IL Indirect Beneficial Owner Large shareholder
Transaction date
Purchase
Price
3.03
Quantity 99,200 +1.9%
Value US$300,556
BVF PARTNERS L P/IL Indirect Beneficial Owner Large shareholder
Transaction date
Purchase
Price
3.04
Quantity 468,000 +10.1%
Value US$1,423,422
BVF PARTNERS L P/IL Indirect Beneficial Owner Large shareholder
Transaction date
Purchase
Price
3.04
Quantity 135,000 +3.0%
Value US$410,602
BVF PARTNERS L P/IL Indirect Beneficial Owner Large shareholder
Transaction date
Purchase
Price
3.04
Quantity 197,300 +4.6%
Value US$600,088
BVF PARTNERS L P/IL Indirect Beneficial Owner Large shareholder
Transaction date
Purchase
Price
2.99
Quantity 48,000 +1.1%
Value US$143,707
BVF PARTNERS L P/IL Indirect Beneficial Owner Large shareholder
Transaction date
Purchase
Price
2.99
Quantity 14,000 +0.3%
Value US$41,915
BVF PARTNERS L P/IL Indirect Beneficial Owner Large shareholder
Transaction date
Purchase
Price
2.99
Quantity 20,100 +0.5%
Value US$60,177
Myers W Todd CFO Officer
Transaction date
Planned sale
Price
1.60
Quantity 781 -3.1%
Value US$1,250
BVF PARTNERS L P/IL Indirect Beneficial Owner Large shareholder
Transaction date
Purchase
Price
1.45
Quantity 644,000 +18.1%
Value US$933,800
BVF PARTNERS L P/IL Indirect Beneficial Owner Large shareholder
Transaction date
Purchase
Price
1.45
Quantity 187,000 +5.5%
Value US$271,150
BVF PARTNERS L P/IL Indirect Beneficial Owner Large shareholder
Transaction date
Purchase
Price
1.45
Quantity 274,257 +8.8%
Value US$397,673
Reich Siegfried VP, Drug Discovery Officer
Transaction date
Planned sale
Price
1.65
Quantity 781 -3.3%
Value US$1,289
Myers W Todd CFO Officer
Transaction date
Planned sale
Price
1.35
Quantity 781 -3.2%
Value US$1,054
Reich Siegfried VP, Drug Discovery Officer
Transaction date
Planned sale
Price
1.45
Quantity 781 -3.4%
Value US$1,132
Myers W Todd CFO Officer
Transaction date
Planned sale
Price
1.43
Quantity 781 -3.3%
Value US$1,117
Reich Siegfried VP, Drug Discovery Officer
Transaction date
Planned sale
Price
1.19
Quantity 481 -2.2%
Value US$572
Reich Siegfried VP, Drug Discovery Officer
Transaction date
Planned sale
Price
1.19
Quantity 300 -1.4%
Value US$357
Myers W Todd CFO Officer
Transaction date
Planned sale
Price
1.30
Quantity 281 -1.3%
Value US$365
Myers W Todd CFO Officer
Transaction date
Planned sale
Price
1.34
Quantity 200 -0.9%
Value US$268
Myers W Todd CFO Officer
Transaction date
Planned sale
Price
1.36
Quantity 200 -0.9%
Value US$272
Myers W Todd CFO Officer
Transaction date
Planned sale
Price
1.37
Quantity 100 -0.4%
Value US$137
Reich Siegfried VP, Drug Discovery Officer
Transaction date
Planned sale
Price
4.01
Quantity 781 -3.7%
Value US$3,132
Myers W Todd CFO Officer
Transaction date
Planned sale
Price
4.05
Quantity 781 -3.6%
Value US$3,163
Reich Siegfried VP, Drug Discovery Officer
Transaction date
Planned sale
Price
4.05
Quantity 781 -3.8%
Value US$3,163
Myers W Todd CFO Officer
Transaction date
Planned sale
Price
4.40
Quantity 781 -3.7%
Value US$3,436
Reich Siegfried VP, Drug Discovery Officer
Transaction date
Planned sale
Price
4.44
Quantity 781 -4.0%
Value US$3,468
Myers W Todd CFO Officer
Transaction date
Planned sale
Price
5.15
Quantity 781 -3.8%
Value US$4,022
Reich Siegfried VP, Drug Discovery Officer
Transaction date
Planned sale
Price
4.75
Quantity 781 -4.2%
Value US$3,710
Myers W Todd CFO Officer
Transaction date
Planned sale
Price
4.85
Quantity 781 -4.0%
Value US$3,788
Reich Siegfried VP, Drug Discovery Officer
Transaction date
Planned sale
Price
5.10
Quantity 781 -4.3%
Value US$3,983
Myers W Todd CFO Officer
Transaction date
Planned sale
Price
6.50
Quantity 781 -4.2%
Value US$5,076
Reich Siegfried VP, Drug Discovery Officer
Transaction date
Planned sale
Price
6.43
Quantity 400 -2.4%
Value US$2,572
Reich Siegfried VP, Drug Discovery Officer
Transaction date
Planned sale
Price
6.42
Quantity 200 -1.2%
Value US$1,284
Reich Siegfried VP, Drug Discovery Officer
Transaction date
Planned sale
Price
6.41
Quantity 181 -1.1%
Value US$1,160
Myers W Todd CFO Officer
Transaction date
Planned sale
Price
6.20
Quantity 781 -4.3%
Value US$4,842
Reich Siegfried VP, Drug Discovery Officer
Transaction date
Planned sale
Price
6.20
Quantity 781 -4.8%
Value US$4,842
Myers W Todd CFO Officer
Transaction date
Planned sale
Price
6.10
Quantity 21 -0.1%
Value US$128
Myers W Todd CFO Officer
Transaction date
Planned sale
Price
6.10
Quantity 200 -1.2%
Value US$1,220
Myers W Todd CFO Officer
Transaction date
Planned sale
Price
6.20
Quantity 560 -3.3%
Value US$3,472
Reich Siegfried VP, Drug Discovery Officer
Transaction date
Planned sale
Price
6.45
Quantity 112 -0.7%
Value US$722
Reich Siegfried VP, Drug Discovery Officer
Transaction date
Planned sale
Price
6.40
Quantity 669 -4.3%
Value US$4,282
Myers W Todd CFO Officer
Transaction date
Planned sale
Price
6.56
Quantity 181 -1.1%
Value US$1,187
Myers W Todd CFO Officer
Transaction date
Planned sale
Price
6.70
Quantity 600 -3.7%
Value US$4,020
Reich Siegfried VP, Drug Discovery Officer
Transaction date
Planned sale
Price
6.05
Quantity 781 -5.3%
Value US$4,725
Myers W Todd CFO Officer
Transaction date
Planned sale
Price
5.33
Quantity 781 -5.0%
Value US$4,163
Reich Siegfried VP, Drug Discovery Officer
Transaction date
Planned sale
Price
5.18
Quantity 100 -0.7%
Value US$518
Reich Siegfried VP, Drug Discovery Officer
Transaction date
Planned sale
Price
5.15
Quantity 100 -0.7%
Value US$515
Reich Siegfried VP, Drug Discovery Officer
Transaction date
Planned sale
Price
5.11
Quantity 581 -4.1%
Value US$2,969
Myers W Todd CFO Officer
Transaction date
Planned sale
Price
5.30
Quantity 781 -5.3%
Value US$4,139
Reich Siegfried VP, Drug Discovery Officer
Transaction date
Planned sale
Price
5.20
Quantity 200 -1.6%
Value US$1,040
Reich Siegfried VP, Drug Discovery Officer
Transaction date
Planned sale
Price
5.19
Quantity 100 -0.8%
Value US$519
Reich Siegfried VP, Drug Discovery Officer
Transaction date
Planned sale
Price
5.18
Quantity 100 -0.8%
Value US$518
Reich Siegfried VP, Drug Discovery Officer
Transaction date
Planned sale
Price
5.17
Quantity 381 -2.9%
Value US$1,970
Myers W Todd CFO Officer
Transaction date
Planned sale
Price
5.08
Quantity 281 -2.1%
Value US$1,427
Myers W Todd CFO Officer
Transaction date
Planned sale
Price
5.00
Quantity 500 -3.6%
Value US$2,500
Reich Siegfried VP, Drug Discovery Officer
Transaction date
Planned sale
Price
5.04
Quantity 202 -1.7%
Value US$1,018
Reich Siegfried VP, Drug Discovery Officer
Transaction date
Planned sale
Price
5.02
Quantity 200 -1.7%
Value US$1,004
Reich Siegfried VP, Drug Discovery Officer
Transaction date
Planned sale
Price
5.01
Quantity 379 -3.0%
Value US$1,899
Myers W Todd CFO Officer
Transaction date
Planned sale
Price
4.61
Quantity 781 -5.9%
Value US$3,600
Reich Siegfried VP, Drug Discovery Officer
Transaction date
Planned sale
Price
5.53
Quantity 100 -0.9%
Value US$553
Reich Siegfried VP, Drug Discovery Officer
Transaction date
Planned sale
Price
5.53
Quantity 681 -5.8%
Value US$3,766
Myers W Todd CFO Officer
Transaction date
Planned sale
Price
4.83
Quantity 781 -6.2%
Value US$3,772
Reich Siegfried VP, Drug Discovery Officer
Transaction date
Planned sale
Price
5.36
Quantity 781 -7.1%
Value US$4,186
Myers W Todd CFO Officer
Transaction date
Planned sale
Price
3.90
Quantity 781 -6.7%
Value US$3,046
Reich Siegfried Vice President, Drug Discovery Officer
Transaction date
Planned sale
Price
3.50
Quantity 9,375 -50.0%
Value US$32,812
Myers W Todd Chief Financial Officer Officer
Transaction date
Planned sale
Price
3.25
Quantity 150 -1.5%
Value US$488
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2008-08-18 2008-08-15 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
33,496 -3.5%
227.39
US$821,312 		33,496 -3.5% 227.39 US$821,312
2008-08-06 2008-08-05 PlS Planned sale Myers W Todd

CFO

Officer
95,647 -27.8%
435.09
US$2,087,386 		95,647 -27.8% 435.09 US$2,087,386
2008-07-16 2008-07-15 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
91,324 +14.9%
53.21
US$51,004 		91,324 +14.9% 53.21 US$51,004
2008-07-16 2008-07-15 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
681 -2.8%
3.05
US$2,077 		681 -2.8% 3.05 US$2,077
2008-07-11 2008-07-11 B Purchase BVF PARTNERS L P/IL

Indirect Beneficial Owner

Large shareholder
7,000 +0.1%
3.07
US$21,489 		7,000 +0.1% 3.07 US$21,489
2008-07-11 2008-07-11 B Purchase BVF PARTNERS L P/IL

Indirect Beneficial Owner

Large shareholder
2,000 +0.0%
3.07
US$6,140 		2,000 +0.0% 3.07 US$6,140
2008-07-11 2008-07-11 B Purchase BVF PARTNERS L P/IL

Indirect Beneficial Owner

Large shareholder
3,500 +0.1%
3.07
US$10,744 		3,500 +0.1% 3.07 US$10,744
2008-07-11 2008-07-10 B Purchase BVF PARTNERS L P/IL

Indirect Beneficial Owner

Large shareholder
236,000 +4.5%
3.03
US$715,033 		236,000 +4.5% 3.03 US$715,033
2008-07-11 2008-07-10 B Purchase BVF PARTNERS L P/IL

Indirect Beneficial Owner

Large shareholder
68,000 +1.3%
3.03
US$206,026 		68,000 +1.3% 3.03 US$206,026
2008-07-11 2008-07-10 B Purchase BVF PARTNERS L P/IL

Indirect Beneficial Owner

Large shareholder
99,200 +1.9%
3.03
US$300,556 		99,200 +1.9% 3.03 US$300,556
2008-07-11 2008-07-09 B Purchase BVF PARTNERS L P/IL

Indirect Beneficial Owner

Large shareholder
468,000 +10.1%
3.04
US$1,423,422 		468,000 +10.1% 3.04 US$1,423,422
2008-07-11 2008-07-09 B Purchase BVF PARTNERS L P/IL

Indirect Beneficial Owner

Large shareholder
135,000 +3.0%
3.04
US$410,602 		135,000 +3.0% 3.04 US$410,602
2008-07-11 2008-07-09 B Purchase BVF PARTNERS L P/IL

Indirect Beneficial Owner

Large shareholder
197,300 +4.6%
3.04
US$600,088 		197,300 +4.6% 3.04 US$600,088
2008-07-11 2008-07-08 B Purchase BVF PARTNERS L P/IL

Indirect Beneficial Owner

Large shareholder
48,000 +1.1%
2.99
US$143,707 		48,000 +1.1% 2.99 US$143,707
2008-07-11 2008-07-08 B Purchase BVF PARTNERS L P/IL

Indirect Beneficial Owner

Large shareholder
14,000 +0.3%
2.99
US$41,915 		14,000 +0.3% 2.99 US$41,915
2008-07-11 2008-07-08 B Purchase BVF PARTNERS L P/IL

Indirect Beneficial Owner

Large shareholder
20,100 +0.5%
2.99
US$60,177 		20,100 +0.5% 2.99 US$60,177
2008-07-07 2008-07-07 PlS Planned sale Myers W Todd

CFO

Officer
781 -3.1%
1.60
US$1,250 		781 -3.1% 1.60 US$1,250
2008-06-20 2008-06-18 B Purchase BVF PARTNERS L P/IL

Indirect Beneficial Owner

Large shareholder
644,000 +18.1%
1.45
US$933,800 		644,000 +18.1% 1.45 US$933,800
2008-06-20 2008-06-18 B Purchase BVF PARTNERS L P/IL

Indirect Beneficial Owner

Large shareholder
187,000 +5.5%
1.45
US$271,150 		187,000 +5.5% 1.45 US$271,150
2008-06-20 2008-06-18 B Purchase BVF PARTNERS L P/IL

Indirect Beneficial Owner

Large shareholder
274,257 +8.8%
1.45
US$397,673 		274,257 +8.8% 1.45 US$397,673
2008-06-17 2008-06-16 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
781 -3.3%
1.65
US$1,289 		781 -3.3% 1.65 US$1,289
2008-06-06 2008-06-05 PlS Planned sale Myers W Todd

CFO

Officer
781 -3.2%
1.35
US$1,054 		781 -3.2% 1.35 US$1,054
2008-05-15 2008-05-15 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
781 -3.4%
1.45
US$1,132 		781 -3.4% 1.45 US$1,132
2008-05-06 2008-05-05 PlS Planned sale Myers W Todd

CFO

Officer
781 -3.3%
1.43
US$1,117 		781 -3.3% 1.43 US$1,117
2008-04-16 2008-04-15 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
481 -2.2%
1.19
US$572 		481 -2.2% 1.19 US$572
2008-04-16 2008-04-15 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
300 -1.4%
1.19
US$357 		300 -1.4% 1.19 US$357
2008-04-08 2008-04-07 PlS Planned sale Myers W Todd

CFO

Officer
281 -1.3%
1.30
US$365 		281 -1.3% 1.30 US$365
2008-04-08 2008-04-07 PlS Planned sale Myers W Todd

CFO

Officer
200 -0.9%
1.34
US$268 		200 -0.9% 1.34 US$268
2008-04-08 2008-04-07 PlS Planned sale Myers W Todd

CFO

Officer
200 -0.9%
1.36
US$272 		200 -0.9% 1.36 US$272
2008-04-08 2008-04-07 PlS Planned sale Myers W Todd

CFO

Officer
100 -0.4%
1.37
US$137 		100 -0.4% 1.37 US$137
2008-03-18 2008-03-17 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
781 -3.7%
4.01
US$3,132 		781 -3.7% 4.01 US$3,132
2008-03-05 2008-03-05 PlS Planned sale Myers W Todd

CFO

Officer
781 -3.6%
4.05
US$3,163 		781 -3.6% 4.05 US$3,163
2008-02-19 2008-02-15 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
781 -3.8%
4.05
US$3,163 		781 -3.8% 4.05 US$3,163
2008-02-05 2008-02-05 PlS Planned sale Myers W Todd

CFO

Officer
781 -3.7%
4.40
US$3,436 		781 -3.7% 4.40 US$3,436
2008-01-16 2008-01-15 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
781 -4.0%
4.44
US$3,468 		781 -4.0% 4.44 US$3,468
2008-01-07 2008-01-07 PlS Planned sale Myers W Todd

CFO

Officer
781 -3.8%
5.15
US$4,022 		781 -3.8% 5.15 US$4,022
2007-12-18 2007-12-17 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
781 -4.2%
4.75
US$3,710 		781 -4.2% 4.75 US$3,710
2007-12-05 2007-12-05 PlS Planned sale Myers W Todd

CFO

Officer
781 -4.0%
4.85
US$3,788 		781 -4.0% 4.85 US$3,788
2007-11-16 2007-11-15 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
781 -4.3%
5.10
US$3,983 		781 -4.3% 5.10 US$3,983
2007-11-05 2007-11-05 PlS Planned sale Myers W Todd

CFO

Officer
781 -4.2%
6.50
US$5,076 		781 -4.2% 6.50 US$5,076
2007-10-15 2007-10-15 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
400 -2.4%
6.43
US$2,572 		400 -2.4% 6.43 US$2,572
2007-10-15 2007-10-15 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
200 -1.2%
6.42
US$1,284 		200 -1.2% 6.42 US$1,284
2007-10-15 2007-10-15 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
181 -1.1%
6.41
US$1,160 		181 -1.1% 6.41 US$1,160
2007-10-05 2007-10-05 PlS Planned sale Myers W Todd

CFO

Officer
781 -4.3%
6.20
US$4,842 		781 -4.3% 6.20 US$4,842
2007-09-17 2007-09-17 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
781 -4.8%
6.20
US$4,842 		781 -4.8% 6.20 US$4,842
2007-09-05 2007-09-05 PlS Planned sale Myers W Todd

CFO

Officer
21 -0.1%
6.10
US$128 		21 -0.1% 6.10 US$128
2007-09-05 2007-09-05 PlS Planned sale Myers W Todd

CFO

Officer
200 -1.2%
6.10
US$1,220 		200 -1.2% 6.10 US$1,220
2007-09-05 2007-09-05 PlS Planned sale Myers W Todd

CFO

Officer
560 -3.3%
6.20
US$3,472 		560 -3.3% 6.20 US$3,472
2007-08-16 2007-08-15 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
112 -0.7%
6.45
US$722 		112 -0.7% 6.45 US$722
2007-08-16 2007-08-15 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
669 -4.3%
6.40
US$4,282 		669 -4.3% 6.40 US$4,282
2007-08-07 2007-08-06 PlS Planned sale Myers W Todd

CFO

Officer
181 -1.1%
6.56
US$1,187 		181 -1.1% 6.56 US$1,187
2007-08-07 2007-08-06 PlS Planned sale Myers W Todd

CFO

Officer
600 -3.7%
6.70
US$4,020 		600 -3.7% 6.70 US$4,020
2007-07-16 2007-07-16 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
781 -5.3%
6.05
US$4,725 		781 -5.3% 6.05 US$4,725
2007-07-09 2007-07-05 PlS Planned sale Myers W Todd

CFO

Officer
781 -5.0%
5.33
US$4,163 		781 -5.0% 5.33 US$4,163
2007-06-19 2007-06-15 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
100 -0.7%
5.18
US$518 		100 -0.7% 5.18 US$518
2007-06-19 2007-06-15 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
100 -0.7%
5.15
US$515 		100 -0.7% 5.15 US$515
2007-06-19 2007-06-15 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
581 -4.1%
5.11
US$2,969 		581 -4.1% 5.11 US$2,969
2007-06-05 2007-06-05 PlS Planned sale Myers W Todd

CFO

Officer
781 -5.3%
5.30
US$4,139 		781 -5.3% 5.30 US$4,139
2007-05-16 2007-05-15 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
200 -1.6%
5.20
US$1,040 		200 -1.6% 5.20 US$1,040
2007-05-16 2007-05-15 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
100 -0.8%
5.19
US$519 		100 -0.8% 5.19 US$519
2007-05-16 2007-05-15 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
100 -0.8%
5.18
US$518 		100 -0.8% 5.18 US$518
2007-05-16 2007-05-15 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
381 -2.9%
5.17
US$1,970 		381 -2.9% 5.17 US$1,970
2007-05-08 2007-05-07 PlS Planned sale Myers W Todd

CFO

Officer
281 -2.1%
5.08
US$1,427 		281 -2.1% 5.08 US$1,427
2007-05-08 2007-05-07 PlS Planned sale Myers W Todd

CFO

Officer
500 -3.6%
5.00
US$2,500 		500 -3.6% 5.00 US$2,500
2007-04-17 2007-04-16 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
202 -1.7%
5.04
US$1,018 		202 -1.7% 5.04 US$1,018
2007-04-17 2007-04-16 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
200 -1.7%
5.02
US$1,004 		200 -1.7% 5.02 US$1,004
2007-04-17 2007-04-16 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
379 -3.0%
5.01
US$1,899 		379 -3.0% 5.01 US$1,899
2007-04-05 2007-04-05 PlS Planned sale Myers W Todd

CFO

Officer
781 -5.9%
4.61
US$3,600 		781 -5.9% 4.61 US$3,600
2007-03-15 2007-03-15 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
100 -0.9%
5.53
US$553 		100 -0.9% 5.53 US$553
2007-03-15 2007-03-15 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
681 -5.8%
5.53
US$3,766 		681 -5.8% 5.53 US$3,766
2007-03-05 2007-03-05 PlS Planned sale Myers W Todd

CFO

Officer
781 -6.2%
4.83
US$3,772 		781 -6.2% 4.83 US$3,772
2007-02-15 2007-02-15 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
781 -7.1%
5.36
US$4,186 		781 -7.1% 5.36 US$4,186
2007-02-05 2007-02-05 PlS Planned sale Myers W Todd

CFO

Officer
781 -6.7%
3.90
US$3,046 		781 -6.7% 3.90 US$3,046
2007-01-16 2007-01-16 PlS Planned sale Reich Siegfried

Vice President, Drug Discovery

Officer
9,375 -50.0%
3.50
US$32,812 		9,375 -50.0% 3.50 US$32,812
2007-01-08 2007-01-05 PlS Planned sale Myers W Todd

Chief Financial Officer

Officer
150 -1.5%
3.25
US$488 		150 -1.5% 3.25 US$488
Explore more

More insider trading research around SGX Pharmaceuticals Inc

More insider trades in United States
Insider trading in North America